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a  b  s  t  r  a  c  t
In recent  years,  optogenetic  approaches  have  signiﬁcantly  advanced  the  experimental  repertoire  of cellu-
lar and functional  neuroscience.  Yet,  precise  and  reliable  methods  for  speciﬁc  expression  of  optogenetic
tools  remain  challenging.  In this  work,  we  studied  the transduction  efﬁciency  of  seven  different  adeno-
associated  virus  (AAV)  serotypes  in  primary  cortical  neurons  and  revealed  recombinant  (r)  AAV6  to  be
the most  efﬁcient  for constructs  under  control  of  the  cytomegalovirus  (CMV)  promoter.  To further  specify
expression  of  the transgene,  we  exchanged  the CMV promoter  for the  human  synapsin  (hSyn)  promoter.
In  primary  cortical-glial  mixed  cultures  transduced  with  hSyn  promoter-containing  rAAVs,  expression
of  ChR2opt  (a Channelrhodopsin-2  variant)  was  limited  to  neurons.  In these  neurons  action  potentials
could  be  reliably  elicited  upon  laser  stimulation  (473  nm).  The  use  of  rAAV  serotype  alone  to restrict
expression  to neurons  results  in  a  lower  transduction  efﬁciency  than  the  use of a broader  transducing
serotype  with  speciﬁcity  conferred  via  a restrictive  promoter.  Cells  transduced  with  the  hSyn  driven gene
expression  were  able  to  elicit  action  potentials  with  more  spatially  and  temporally  accurate  illumination
than  neurons  electrofected  with  the  CMV  driven  construct.  The  hSyn  promoter  is particularly  suited  to
use in  AAVs  due  to its  small  size.  These  results  demonstrate  that  rAAVs  are versatile  tools  to mediate
speciﬁc  and  efﬁcient  transduction  as  well  as functional  and  stable  expression  of  transgenes  in primary
cortical  neurons.
©  2016  The  Authors.  Published  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-ND. Introduction
Optogenetic approaches have promoted in vitro and in vivo
xperiments investigating cellular signaling and neuronal network
ctivity with high temporal and spatial resolution (Arenkiel et al.,
007; Gradinaru et al., 2007; Madisen et al., 2012; Avermann
t al., 2012; Huber et al., 2008; Desai et al., 2011; Lin et al., 2013;
awydow et al., 2014; Renault et al., 2015). Beyond modulating
nd monitoring neuronal network properties, optogenetic methods
ave been applied to control signaling in sperm (Jansen et al., 2015)
nd to stimulate gene expression (Folcher et al., 2014; Konermann
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et al., 2013; Ye et al., 2011). Optogenetic experiments, however,
require efﬁcient introduction and expression of light-sensitive pro-
teins into cells or tissue.
The blue light-gated cation channel Channelrhodopsin-2 (ChR2)
is an intensely studied optogenetic tool (Nagel et al., 2003, 2005b;
Boyden et al., 2005; Li et al., 2005; Petreanu et al., 2007; Ishizuka
et al., 2006; Dawydow et al., 2014). The heterologous expression
of ChR2 in electrogenic cells such as neurons can be utilized to
depolarize the cell’s membrane potential, thereby evoking action
potentials (Zhang et al., 2006; Wang et al., 2007). Since its discovery,
numerous ChR2 variants have been engineered to improve prop-
erties, such as expression level, closing dynamics (Dawydow et al.,
2014; Gunaydin et al., 2010), and stable photo-switching (Berndt
et al., 2009). In addition to triggering action potentials, ChR2 can be
employed to silence neuronal activity by changing its ion selectiv-
ity to anions (Wietek et al., 2014; Berndt et al., 2014). Fluorescent
tags such as mKate and YFP fused to ChR2 have been used to iden-
tify cells expressing ChR2 and to assess its subcellular distribution
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Shcherbo et al., 2007; Nagel et al., 2005a), as light-induced manip-
lation of neuronal electrical activity depends on the expression
evel of ChR2 in the cell membrane (Lin et al., 2013).
Furthermore, powerful gene delivery approaches are required
or effective optical control of neuronal activity. However, standard
ransfection strategies can be problematic due to low cell viabil-
ty and low speciﬁcity, especially for primary post-mitotic neurons
Watanabe et al., 1999; Martinez and Hollenbeck 2003; Hamm
t al., 2002; Zeitelhofer et al., 2009; Karra and Dahm 2010). There-
ore, we assessed recombinant adeno-associated viruses (rAAVs)
s a tool for gene transfer. AAVs are non-pathogenic, have a low
mmunogenicity, and are known to transduce dividing and non-
ividing cells (Blacklow et al., 1968; During 1997; Hernandez
t al., 1999). There are numerous serotypes with different tissue
ropisms, permitting speciﬁc transduction of a wide range of cell
ypes (Howard et al., 2008); reviewed in Asokan et al. (2012).
In this work, we identiﬁed rAAV6 as the most efﬁcient serotype
or transduction of cortical-glial mixed cultures. We  were ﬁrst
oncerned which serotype of rAAV was most efﬁcient at transduc-
ng cortical neurons. Therefore, we used the constitutively active
ytomegalovirus (CMV) promoter (Wilkinson and Akrigg, 1992) to
rive ChR2opt gene expression. The protein was detected to varying
egrees in neurons as well as in glia cells from each of the applied
erotypes. After exchanging the CMV  promoter for the human
ynapsin (hSyn) promoter, ChR2opt expression was  restricted to
eurons, without loss of transduction efﬁciency. Other restrictive
romoters might be considered as well, e.g. FNPY or CamKIIa, but
he compact size of hSyn (only 485 bp, vs. approx. 2600 bp for FNPY
Nathanson et al., 2009) and 1290 bp for CamKIIa (Yizhar et al.,
011)) is favorable for packaging, even large gene constructs into
AV virions. Here, we succeeded in controlling electrical activity
n primary cortical neurons expressing ChR2opt and in triggering
ction potentials by blue light stimulation of ChR2opt. Using this
trategy, we were able to trigger responses at the single cell level
ith high temporal accuracy.
. Materials and methods
.1. Cortical cultures
Primary cortical cultures were prepared as described previ-
usly (Brewer et al., 1993). Brieﬂy, cortices from embryonic day
8 (E18) Wistar rat (Charles River, Germany) brains were dissected
nd mechanically dissociated by trituration with a ﬁre-polished,
ilanized pasteur pipette in 1 ml  Hank’s balanced salt solution
ithout calcium or magnesium (HBSS-) (0.035% sodium bicar-
onate, 1 mM pyruvate, 10 mM HEPES, 20 mM glucose, pH 7.4).
he cell suspension was diluted 1:2 in HBSS+ (with calcium and
agnesium) and non-dispersed tissue was allowed to settle for
 min. The supernatant was centrifuged for 2 min  at 200g. The pel-
et was resuspended in 1 ml  Neurobasal medium (Gibco, Paisley,
K) with 1% B-27 (Gibco, Grand Island, NY, USA) and 0.5 mM l-
lutamine (Gibco, Paisley, UK) and 50 g/ml gentamicin (Sigma,
teinheim, Germany) (NB) per hemisphere. The cells were counted
n a Neubauer counting chamber and plated in a concentration
f 50,000 cells per well (24-well-plate) on poly-d-lysine (PDL,
0 g/ml) coated 12 mm  coverslips. Cells were kept at 37 ◦C, 5%
O2 and 100% humidity in 500 l NB. After 4 h, the medium was
xchanged for 500 l NB/well. Every third day, half of the medium
as exchanged or, for rAAV transduced cultures, 100 l NB medium
as added in order to keep the neurons maximally exposed to the
nitially added rAAV particles.
This work was carried out with the approval of the
andesumweltamt für Natur, Umwelt und Verbraucherschutzlogy 233 (2016) 171–180
Nordrhein-Westfalen, Recklinghausen, Germany, in accordance
with §6  TierschG., §4 TSchG i.V. and §2  TierSchVerV.
2.2. Plasmids and cloning
Codon optimization for expression in mammalian cells was
performed on the H134R variant of Channelrhodopsin-2 from C.
reinhardtii using the software package JCat (Grote et al., 2005). In
order to facilitate identiﬁcation of transfected cells without sig-
niﬁcant spectral overlap with Channelrhodopsin-2 absorbtion, the
ﬂuorescent protein mKATE was fused to the C-terminus of the chan-
nel. A linker of 15 nucleotides encoding the amino acid residues
AVATI was inserted to separate the channel from the ﬂuorophore
mKATE. The 3′ end of mKATE was  extended by 21 nucleotides cod-
ing for a FCYENEV motif that has been shown to serve as an ER
export signal in a vertebrate potassium channel (Gradinaru et al.,
2010). The ﬁnal construct, which we  deem ChR2opt, was synthe-
sized by GeneArt AG (Regensburg, Germany) and subcloned into
the TRex system’s TetON plasmid backbone (Invitrogen, Darm-
stadt, Germany). This construct was validated in electrofection
experiments using Lonza’s Rat Nucleofector Kit and patch clamp
electrophysiology in both HEK293 cells and primary cortical neu-
rons. The gene encoding portion of the construct was then further
subcloned to allow for packaging into AAV vectors.
The rAAV vector pscAGFPFG2 was kindly provided by Dr. Hilde-
gard Büning (Labor für AAV-Vektorentwicklung, CMMC,  Cologne,
Germany). The pAAV-hSyn-RFP construct was  obtained from
Addgene (Addgene plasmid #22907). ChR2opt is available in
Addgene plasmid #67958. The rAAV vectors psc-CMV-ChR2opt and
psc-hSyn-ChR2opt were generated using restriction digest-based
strategies. For the generation of the psc-CMV-ChR2opt vector, the
ChR2opt-encoding fragment was inserted into the pscAGFPFG2
vector after excision of GFP. Based on this plasmid, the psc-hSyn-
ChR2opt vector was generated by exchanging the CMV  promoter
for the hSyn promoter fragment.
2.3. Viral vector generation
Recombinant adeno associated viral (rAAV) vectors were
generated by transient transfection of HEK293 cells (obtained
from ATCC). HEK293 cells were cultivated in DH10 medium
(DMEM + Glutamax (Invitrogen), 10% (v/v) FBS (Gibco), 1% (v/v)
antibiotics/antimycotics (Invitrogen)) at 37 ◦C, 5% CO2, and 95% rel-
ative humidity. Brieﬂy, 24 h prior to transfection 107 cells were
seeded on Ø 14.5 cm dishes (10 dishes/rAAV construct). Cells were
triple-transfected with the vector plasmid providing the transgenic
viral genome, as well as the helper plasmids pRC (Girod et al.,
1999) and pXX6-80 (Xiao et al., 1998), using the calcium phosphate
method modiﬁed from (Chen and Okayama, 1987). Plasmid DNA
was diluted in CaCl2 (250 mM)  and HEPES-buffered saline (50 mM
HEPES, 280 mM NaCl, 1.5 mM Na2HPO4, pH 7.12), incubated for
3 min  at RT, and added to HEK293 cells. After 24 h incubation
at 37 ◦C, 5% CO2, and 95% relative humidity, the medium was
exchanged for DH10 with reduced FBS (DMEM + Glutamax, 2% (v/v)
FBS, 1% (v/v) antibiotics/antimycotics). Cells were harvested in PBS-
M/K  (in mM:  NaCl 130, KCl 2.5, MgCl2 1, Na2HPO4 70, NaH2PO4 30,
pH 7.4) after 24 h and collected by centrifugation.
Cells were lyzed in lysis buffer (in mM:  NaCl 150, Tris/HCl
50, pH 8.5) by four freeze/thaw-cycles in liquid nitrogen and
at 37 ◦C. Nucleic acids were digested with benzonase (50 U/ml;
Merck) for 30 min  at 37 ◦C. After removal of cell debris by
centrifugation rAAV particles were enriched by density gradi-
ent centrifugation. The rAAV suspension was sub-layered with
iodixanol (Sigma-Aldrich, Taufkirchen, Germany) solutions (15%,
25%, 40%, and 60% iodixanol) and centrifuged (264,000g, 4 ◦C,
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as collected and viral titers were determined by quantita-
ive PCR. Brieﬂy, viral genomes were isolated using the DNeasy
lood & Tissue Kit (Qiagen, Hilden, Germany) and genomic
iters were determined. Primer pairs framing deﬁned DNA seg-
ents of promoter or transgene sequences were used: for
he CMV  promoter (CGCTATTACCATGGTGATGCG, CCTCCCACCG-
ACACGCC), for the hSyn promoter (CCTGCGTATGAGTGCAAGTG,
GTGCTGAAGCTGGCAGTG), and for the eGFP-encoding sequence
GACGTAAACGGCCACAAGTTC, GAAGTCGTGCTGCTTCATGTG).
.4. AAV transduction
Primary cortical cells, grown on PDL coated coverslips (12 mm),
ere transduced with rAAVs on DIV1 or DIV8 with different mul-
iplicities of infection (MOI). The medium (500 l) was  completely
xchanged with NB containing 107, 108, 109, 1010 or 1011 viral
enomes to achieve MOIs of 2 × 102, 2 × 103, 2 × 104, 2 × 105 and
 × 106 viral particles per cell (vp/cell), respectively. As a control,
he same volume of 40% iodixanol was added to individual wells.
hree days post transduction (DPT), 100 l NB medium was added.
he cells were electrophysiologically measured after DIV14 or ﬁxed
or immunoﬂuorescence DPT7-9.
.5. Electrophysiology
Whole cell patch clamp experiments were performed using an
PC9 ampliﬁer (HEKA Elektronik, Lambrecht/Pfalz, Germany) con-
rolled by the TIDA 5.240 software (HEKA Elektronik) (Zhu et al.,
016). Cortical neurons were recorded between DIV14 and 16 in the
urrent clamp mode (with a holding membrane current leading to
 membrane potential of −70 mV). The recordings were performed
n extracellular patch clamp buffer solution (mM:  NaCl 120, KCl 3,
gCl2 1, HEPES 10, CaCl2 2; pH 7.3, 248 mosm kg−1). Patch pipettes
ere pulled from borosilicate glass capillaries (Sutter Instrument
o., Novato, CA, USA) using a micropipette puller (P-2000, Sutter)
o achieve a pipette resistance of 6–9 MOhm.  The pipettes were
lled with intracellular patch solution (mM:  NaCl 2, KCl 120, MgCl2
, HEPES 5, EGTA 0.2, Mg-ATP 0.20, pH 7.3, 255 mosm kg−1). Cells
ere excluded if the membrane resistance was outside of the range
rom 50 MOhm to 300 MOhm and the series resistance of neurons
as higher than 26.4 MOhm.  Spiking was measured while inject-
ng current to keep the voltage of neurons at approximately −70 mV
holding current ranging from 0 pA to −200 pA).
.6. Laser stimulation
ChR2opt-expressing neurons were randomly chosen and stim-
lated with a 473 nm diode laser (Rapp OptoElectronic GmbH,
amburg, Germany) which was guided through an optical ﬁber
nd reﬂected with a dichroic mirror (UGA-40, Rapp OptoElec-
ronic GmbH) into the light path of a Zeiss Axioscope microscope
quipped with an Olympus (x20) objective (UMPLFLN20xW). The
aser spot diameter was adjusted to about 24 m,  resulting in
 laser intensity of approximately 1.74 W mm−2. Different delay
imes (150 ms  or 200 ms  or 500 ms)  and different laser pulse times
ranging from 1 ms  to 50 ms)  were applied for ChR2opt stimulation
argeting somas/axons/dendrites.
.7. Immunoﬂuorescence
For the immunostaining, cells were ﬁxed with 4% (w/v)
araformaldehyde in PBS (PFA) at RT for 20 min, washed with
 x PBS (pH 7.4) and blocked overnight in blocking solution (1%
w/v) BSA, 2% (v/v) goat serum in PBS). Cells were permeabilized
ith 0.1% (w/v) TritonX-100 in blocking buffer for 15 min. Thelogy 233 (2016) 171–180 173
following primary antibodies were used: rabbit anti-MAP2 (Cata-
logue number: AB5622, dilution 1:500, Chemicon/Millipore) and
mouse anti-GFAP (Catalogue number: MAB3402, dilution 1:100,
Chemicon/Millipore). Bound primary antibodies were visualized
using Alexa-488 (A-11029), Alexa-546 (A-11003) or Alexa-633
(A-21071)-conjugated secondary antibodies (Life technologies,
Eugene, Oregon, USA; dilution 1:500 in blocking solution). Nuclei
were stained with TOPRO (Life technologies, Eugene, Oregon,
USA; dilution 1:500 in blocking solution). Samples were mounted
in Dako Fluorescence Mounting Medium (Agilent Technologies,
Waldbronn, Germany) and analyzed by using a Zeiss Apotome
microscope (Carl Zeiss Microscopy GmbH, Göttingen, Germany) or
Confocal laser scanning microscope (Leica TCS SP5, Leica Microsys-
tems, Heidelberg, Germany).
3. Results
3.1. Transduction efﬁciency of rAAV serotypes in primary cortical
cultures
We were able to show proof of principle stimulation of neurons
expressing ChR2opt after electrofection with ChR2opt encoding
plasmid constructs. However, the area of membrane necessary for
illumination and the duration of illumination were not satisfactory
for high precision stimulation. Therefore, we sought alternatives
to improve expression levels that eventually could reduce the area
and duration of illumination necessary to trigger a light-evoked
action potential. In order to achieve this goal, we wanted to evalu-
ate the transduction efﬁciencies of different rAAV serotypes in rat
primary cortical cultures that contained both neurons and glia. Ini-
tially, rAAV serotypes 1, 2, 4, 5, 6, 8, and 9 mediating expression
of eGFP under the control of the CMV  promoter were investigated.
Viral vectors were applied with different multiplicity of infection
(MOI) values, i.e. 2 × 103, 2 × 104, 2 × 105 and 2 × 106 vp/cell, on
cortical-glial mixed cultures after 8 days in vitro (DIV8). All of the
applied rAAV serotypes mediated expression of eGFP, but trans-
duction efﬁciencies and eGFP expression levels varied between
serotypes (Table 1 and Fig. S1). Due to the constitutively active CMV
promoter eGFP expression was  observed in neuronal, as well as glial
cells. The ratio of transduced neuronal vs. transduced glial cells was
examined using a neuronal marker (microtubule-associated pro-
tein 2, MAP2) and an astrocyte marker (glial ﬁbrillary acidic protein,
GFAP). Serotype 6 mediated the most efﬁcient transduction in pri-
mary cortical-glial mixed cultures (Table 1 and Fig. 1). However,
even though the highest neuron transduction rate was observed
for serotype 6, glial cells were also transduced (Fig. 1). Therefore,
the serotype-dependent tropism was a ﬁrst step towards a cell-type
(here neuron) speciﬁc transgene expression.
3.2. Neuron-speciﬁc expression of ChR2opt in primary cortical
neurons
Based on the results described above, we selected rAAV6
for transgene expression in cortical neurons. For optogenetic
approaches, we  generated a rAAV6 vector to express ChR2opt
under the control of the CMV  promoter. The rAAV6-CMV-ChR2opt
construct mediated expression of the transgene in about 83% of
neurons. Immunocytochemical staining revealed that ChR2opt was
mainly expressed in neuronal cells, but also in about 63% of GFAP-
positive cells (Fig. 2 and Fig. 3B). Fluorescence of the C-terminal
mKate tag could be detected on DPT3 and increased until DPT7.
These results corroborate the data for CMV  promoter-mediated
eGFP expression after transduction with different rAAV serotypes
(Table 1 and Fig. S1).
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Table 1
Transduction efﬁciency of different rAAV serotypes in primary cortical-glial mixed cultures.
Serotype Expression level Transduced neurons (total MAP2 positive) Transduced glial cells (total GFAP positive)
1 ++ ++ +++
2  + + ++
4  + + +++
5  + + +
6  +++ +++ ++
8  + + –
9  + + +++
Primary cortical-glial mixed cultures were transduced on DIV8 with rAAV serotypes 1, 2, 4, 5, 6, 8, and 9 expressing eGFP under the control of the CMV  promoter (MOI 2 × 104
vp/cell). Transduction efﬁciencies were estimated based on eGFP ﬂuorescence (DPT9). Cell types were identiﬁed using the neuronal marker MAP2 and the glial marker GFAP.
Percentages of transduced neurons and glial cells were estimated based on total MAP2 or GFAP-positive cells, respectively. Mean values (n = 3 independent experiments;
each  one includes three samples) were calculated and are depicted as – (no transduced cells), + (≤ 30%), ++ (30–66%), and +++ (≥ 66%).
Fig. 1. Expression of eGFP in primary cortical-glial mixed cultures.
Primary cortical-glial mixed cultures were transduced with rAAV6-CMV-eGFP (MOI 2 × 104 vp/cell) on DIV8 (upper panel) or treated with iodixanol as a control (lower panel).
Immunocytochemistry was  performed on DIV15 and cultures were stained using speciﬁc antibodies for MAP2 (B, blue) and GFAP (C, red). Fluorescence of eGFP is shown in
green  (A) and the merged images are depicted in (D). Arrows identify eGFP-positive glial cells and asterisks mark eGFP-expressing neurons. Scale bars indicate 50 m.  (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 2. Expression of ChR2opt in primary cortical-glial mixed cultures.
Primary cortical-glial mixed cultures were transduced with rAAV6-CMV-ChR2opt (MOI 2 × 104 vp/cell) on DIV8 (upper panel) or treated with iodixanol as a control (lower
panel).  Immunocytochemistry was performed on DIV15 and cultures were stained using speciﬁc antibodies for MAP2 (B, blue) and GFAP (C, green). Fluorescence of mKate
is  shown in red (A) and the merged images are depicted in (D). Arrows identify mKate-positive glial cells and asterisks mark mKate-expressing neurons. Scale bars indicate
20  m.  For typical staining of cells without rAAV and without iodixanol treatment, see Fig. S2. (For interpretation of the references to colour in this ﬁgure legend, the reader
is  referred to the web version of this article.)
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Fig. 3. Neuron-speciﬁc expression of ChR2opt in primary cortical-glial mixed cultures.
(A) Primary cortical-glial mixed cultures were transduced with rAAV6-hSyn-RFP (MOI 2 × 104 vp/cell) on DIV8 and stained immunocytochemically on DIV14 for MAP2 (blue,
top,  middle) and GFAP (green, bottom, middle). Fluorescence of RFP is shown in red and the merged images are depicted on the right. Scale bars indicate 20 m. (B) Neuron
transduction efﬁciencies of rAAV6 vectors (DIV14) harboring different promoters. The data are mean values ± SEM (n = 3 independent experiments. In one experiment, 10
different areas of each coverslip containing neurons were imaged for analysis). (C) Primary cortical-glial mixed cultures were transduced with rAAV6-hSyn-ChR2opt (MOI
2  × 103 vp/cell) on DIV8 and stained immunocytochemically on DIV15. Autoﬂuorescence of mKate is depicted in red, MAP2 staining in blue (top, middle), and GFAP staining
in  green (bottom, middle). The merged images are shown on the right. Scale bars indicate 20 m.  (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web  version of this article.)





























































Fig. 4. Stimulation of ChR2opt – expressing neurons.
(A) Neurons transduced with a rAAV6 construct harboring either the CMV  promoter
(black, red) or the hSyn promoter (blue) were examined. Successful generation of
action potentials (%) is displayed vs. pulse duration of the light stimulus. Data (n = 3–7
cells for rAAV6-CMV-ChR2opt group; n = 3–4 cells for rAAV6-hSyn-ChR2opt group)
are presented as mean ± SEM. Each stimulation was  repeated 100 times. (B) An extra
spike was  triggered by longer pulse times in a rAAV6-CMV-ChR2opt transduced76 L. Jin et al. / Journal of Biot
Subsequently, we substituted the CMV  promoter for the
euron-speciﬁc human synapsin 1 (hSyn) promoter to further
mprove neuronal expression levels while reducing glial ChR2opt
xpression. Firstly, we assessed the expression pattern of a rAAV6-
Syn-RFP construct in primary cortical-glial mixed cultures based
n RFP ﬂuorescence. Immunocytochemical staining with MAP2
nd GFAP antibodies revealed a very high percentage of RFP-
ositive neurons, whereas glia cells did not express the ﬂuorescent
rotein (Fig. 3A). The neuron transduction efﬁciency of 92% ± 5%
chieved with rAAV6-hSyn-RFP (MOI 2 × 102 vp/cell) was  higher
han observed for rAAV6-CMV-eGFP (MOI 2 × 104 vp/cell). Appli-
ation of rAAV6-hSyn-RFP with an MOI  of 2 × 104 vp/cell further
ncreased the neuron transduction efﬁciency to 96% ± 2% (Fig. 3B).
n summary, the hSyn promoter not only mediated neuron-speciﬁc
ransgene expression but also seemed to improve transduction
nd/or expression efﬁciency compared to the CMV  construct. Next,
e probed whether ChR2opt could also be speciﬁcally expressed
n primary rat cortical neurons with the hSyn promoter via rAAV6-
ediated transduction. A transduction efﬁciency of 70% ± 8% was
chieved (Fig. 3B). As depicted in Fig. 3C, mKate ﬂuorescence was
learly visible in neurons while glial cells did not express the pro-
ein. This result is the same as what we observed for hSyn-RFP
xpression (Fig. 3A).
.3. Optical stimulation of ChR2opt-expressing neurons
In order to test for ChR2opt functionality in triggering action
otentials, we performed optical stimulation experiments. Single
hR2opt-expressing neurons were stimulated using blue laser light
473 nm)  with a spot size of approximately 24 m in diameter (laser
ntensity of 1.74 W mm−2). Cells were analyzed using the whole cell
atch clamp technique.
We  probed how many action potentials (= spikes) were elicited
ith different light pulse durations using the same interstimu-
us delay times for ChR2opt recovery. In Fig. 4A experiments are
hown where ChR2opt was expressed under the control of the
MV  promoter (rAAV6-CMV-ChR2opt). Two different delay times
150 ms  or 200 ms)  and ﬁve different laser pulse times (ranging
rom 1 ms  to 30 ms)  were applied for ChR2opt stimulation. Spikes
ere more easily evoked with longer pulse times than with shorter
ulse times. Using a 10 ms  laser pulse, spikes were triggered with
 success rate of 83% ± 8%. Successive stimuli were applied with
nterpulse delay times of 150 ms.  The stimulation success rate
ncreased to 97% ± 2% if the delay time was extended to 200 ms.
ccordingly, measurements of cells transduced with rAAV6-hSyn-
hR2opt were performed with stimulation pulses interrupted with
elay times of 200 ms.  Under these conditions, pulse times of ≥5 ms
esulted in successful spike generation rates of up to 99%. Further-
ore, we addressed eventual triggering of extra spikes. As depicted
n Fig. 4B pulse times of 50 ms  evoked an extra spike. Using 30 ms
ulses, a second depolarization was measured but it did not reach
he threshold level to induce another action potential. The pho-
ocurrent of Channelrhodopsin consists of a peak current and a
tationary current (Berndt et al., 2011). Our data suggest that dur-
ng the stationary photocurrent that can be induced with a longer
timulation pulse, some channels remain open. These channels may
eep the cell depolarized and trigger an additional action potential
specially when long light stimuli (50 ms)  are applied.
Having demonstrated the ability of ChR2opt to trigger action
otentials at the soma, we  next investigated whether illumination
f axons or dendrites of a transduced neuron were sufﬁcient to
voke action potentials. Five different sites including the soma of a
hR2opt expressing neuron were selected for stimulation (Fig. 5A,
sterisks). Action potentials were recorded at the soma with whole
ell patch clamping. As we had demonstrated before (Lange et al.,
014), action potentials could be precisely and repeatedly trig-neuron. (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)
gered at each of 5 different sites with 100 laser pulses of 50 ms
duration and a delay time of 500 ms  (Fig. 5B). We  also examined
the dependence of the response time and spike amplitude to the
distance of the stimulation site. The time from the onset of illumi-
nation to spike peak measured at the soma was  deﬁned as response
time. As depicted in Fig. 5C, response times decreased with smaller
distances between the stimulation site and the patch pipette. Stim-
ulation at position 5 (see Fig. 5A) triggered an action potential
after 18.4 ± 0.2 ms,  whereas stimulation at the soma (position 1)
caused an action potential approximately after 12.1 ± 0.2 ms.  The
amplitudes of the action potentials were very similar and were
independent of the stimulation site (Fig. 5D). Similar effects were
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Fig. 5. Stimulation of rAAV6-CMV-ChR2opt-transduced neurons.
(A) Autoﬂuorescence of mKate tagged to ChR2opt is displayed. The ﬁve stimulation sites are indicated by asterisks (positions 1–5). The scale bar represents 50 m. (B)
Voltage traces of 10 successive stimulations (50 ms  pulses with 500 ms  interpulse delay times) initiated at the 5 different stimulation sites (see Fig. 5A) were recorded from
a  single cell by whole cell patch clamping. (C) Response time to evoke an action potential measured at the soma after light stimulation (473 nm)  at each of the ﬁve different
s poten






















Ctimulation sites (see Fig. 5A) (one-way ANOVA, p < 0.001) are depicted. (D) Action 
timulation sites are shown. Data (n = 50 trials from one cell) are presented as mean
eferred to the web  version of this article.)
een on additional cells tested independently with varying num-
ers of illumination points distant from the soma (n = 4). However,
ince each response is dependent on cell morphology and the exact
osition illuminated during stimulation, it is not possible to pool
istance vs. delay data across cells.
Similar to CMV-driven expression of ChR2opt, neurons trans-
uced with rAAV6-hSyn-ChR2opt generated action potentials after
timulation with blue laser light (n = 15). In Fig. 6A a representa-
ive trace is depicted using a laser pulse of 50 ms and a delay time
f 500 ms.  When applying 50 ms  pulses, again, often more than
ne spike was evoked. The success rate of triggering the ﬁrst spike
as 100%, whereas the success rate to trigger a second spike was
5% ± 22% (Fig. 6B). A comparison of the FWHM (Full-Width Half-
aximum) and the amplitude of both the ﬁrst and second spike
fter light stimulation revealed that the FWHM of the ﬁrst spike was
maller than that of the second one (Fig. 6C), while the amplitude
f ﬁrst spike was larger than that of the second one (Fig. 6D).
. Discussion
Recombinant AAV vectors are promising tools for gene delivery
oth, in vitro and in vivo. Multiple naturally occurring serotypes
ave been demonstrated to target cells in different tissues and
rgans, including the brain (Aschauer et al., 2013; Schultz and
hamberlain 2008). The transduction efﬁciency of cells or tissuetial amplitudes measured after light stimulation (473 nm) at each of the 5 different
. (For interpretation of the references to colour in this ﬁgure legend, the reader is
strongly depends on the AAV serotype and its binding partners on
the cell surface (Cearley and Wolfe, 2006). In this work, we have
examined the transduction efﬁciency of different rAAV serotypes
in rat primary cortical-glial mixed cultures and found that rAAV6
is best suited to gain high-efﬁciency transduction rates. AAV5
has been used as a safe and effective viral vector for trans-
gene expression in the brains of non-human primates (Diester
et al., 2011). However, rAAV5 showed the lowest efﬁciency for
transgene expression in rat primary cortical-glial mixed cultures
(Table 1). Mechanical preparation of the primary cortical neurons
preserves their surface proteins, therefore we do not expect a sig-
niﬁcant difference in transduction rate in vivo compared to our
in vitro tests. Comparative studies using different AAV serotypes
and adenoviruses as well as lentiviruses showed that AAVs were
advantageous when testing transduction efﬁcacy and stability of
gene expression (Doherty et al., 2011; Ehrengruber et al., 2001;
Mason et al., 2010; Vandendriessche et al., 2007). We  used a sim-
ilar approach as applied by (Mason et al., 2010) to examine which
rAAV serotype would efﬁciently transduce cortical-glial mixed cul-
tures. The rAAV6 serotype including the neuron-speciﬁc promoter
hSyn turned out to be the most efﬁcacious viroid. Applying viral
suspensions to our in vitro cultures did not impair viability of the
samples for up to 3 weeks. Since rAAVs can also be administered to
living animals either by systemic or tissue-limited injection, such
approaches would tremendously reduce the time required to gen-
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Fig. 6. Triggering action potentials in rAAV6-hSyn-ChR2opt transduced neurons.
(A)  Comparison of action potentials in a typical rAAV6-hSyn-ChR2opt transduced neuron. A voltage trace (black) driven by 80 pA injection from the patch pipette, a
representative voltage trace (red) of APs evoked by laser pulse application for 50 ms  separated by a delay time of 500 ms,  and a spontaneous action potential (green) are
shown. (B) Success rate (%) of action potential generation in response to a light stimulus is depicted for the ﬁrst and second spike. (C) The scheme of the amplitude and FWHM
(Full-Width at Half-Maximum) in one spike are depicted in blue and green color, respectively. ‘Max’ indicates the maximum of depolarization from the resting potential. (D)
A ed. (E































implitudes of the ﬁrst and second spikes (one-way ANOVA, p < 0.001) were analyz
n  = 300 spikes from one cell for the ﬁrst spike group; n = 164 spikes from the sam
eferences to colour in this ﬁgure legend, the reader is referred to the web version o
rate transgenic animals and/or breed genetically modiﬁed mouse
trains for offspring to be analyzed.
The ability to transfer a target gene into a speciﬁc cell type is an
ssential aspect of biomedical research. The speciﬁc expression of
hR2opt in this work would be useful for the ﬁeld of optogenetics.
he human synapsin 1 promoter confers neuron-speciﬁc transgene
xpression (Kügler et al., 2003). Our data have shown that the inci-
ence of ChR2opt or RFP expression was dramatically decreased in
lial cells using the hSyn promoter (Fig. 3B). In contrast, the com-
only used CMV  promoter led to gene expression in neuronal as
ell as glial cells (Fig. 2). In addition, we observed more action
otentials and even multiple action potentials in response to one
ight pulse in neurons that had been transduced with rAAV6-hSyn-
hR2opt rather than rAAV6-CMV-ChR2opt.
It has been described that the strength of depolarization and the
elay time between two action potentials that result from ChR2
timulation depend on the expression level of Channelrhodopsin
Lin et al., 2013). We  found that CMV-driven ChR2opt expression is
ufﬁcient for generating action potentials by illuminating the axon
ith a pulse of blue light. The illuminated area of the axon is much
maller than the total laser spot area, which was about 450 m2. In
ontrast, light stimuli delivered to the cell’s soma cover an area that
as approximately the same size as the laser spot. Our data support
he notion that neuronal activity can be evoked by blue light from
lmost any area of single, ChR2opt-expressing neurons.
In order to elicit sufﬁcient photocurrent for depolarizing a neu-
on, the expression time of ChR2opt may  play a signiﬁcant role.
xpression of the mKate tag fused to ChR2opt was already visible
hree days after transduction. However, a longer expression time
learly improved detection of the ﬂuorescent tag. We  observed con-
incing expression levels at 7DPT that is DIV15 (Fig. 2) and laser
timulation of neurons synthesizing ChR2opt reproducibly resulted
n the generation of action potentials.) FWHM of the ﬁrst and second spikes (one-way ANOVA, p < 0.001) is shown. Data
for the second spike group) are presented as mean ± SD. (For interpretation of the
 article.)
When stimulating different locations in one single neu-
ron, response times were signiﬁcantly different if targeting the
axon/dendrites or the soma (Fig. 5C). We calculated the speed of
action potential propagation from the stimulated site to the soma.
These were in the range of 18–44 m ms−1.
When multiple spikes were elicited by a single light stimula-
tion, the amplitude of the ﬁrst spike was  larger than that of the
second one (Fig. 6D). The reduction in spike amplitude may  indi-
cate a depolarization block due to overly large photocurrents as
has been shown for a ChR2 mutant, i.e., hSyn-ChR2(T159C) (Berndt
et al., 2011). A similar reduction in the amplitude of the second
spike was  found when the cell was stimulated by direct current
injection from the pipette. 60 or 80 pA injections resulted in mul-
tiple spikes, with a reduction of down to 74% of the initial spike
(n = 4 pairs). The persistent photocurrent during the ﬁrst spike may
prevent recovery of voltage-gated sodium channels from inactiva-
tion (Bendahhou, 2012). This might imply that if the photocurrent
of Channelrhodopsin is too large, it may  result in ceasing neuronal
activity. Since spikes were triggered with a delay of approximately
10 ms,  the illumination time could be reduced to 10–15 ms to allow
faster repolarization after the spike. Alternatively, this phenom-
ena could be employed to achieve stimulation and inhibition of
neurons with a single optogenetic construct. Slow acting Channel-
rhodopsin variants, such as those reported by Nagel et al. (2005a,b)
and Lin et al. (2013) are suited to utilizing residual currents for a
dual stimulation and inhibition system with a single light source.
We have observed successful transduction of primary cortical-
glial mixed cultures with rAAV6 constructs. Though other serotypes
showed a lower ability to transduce glia cells, the accompanying
poor transduction efﬁciency of neurons calls for an appropriate
ability to achieve neuronal expression, e.g., by employing the hSyn
promoter. The hSyn driven ChR2opt expression allowed us to reli-
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≥5 ms)  and illumination areas down to 96 m2, which is the sur-
ace area of an axon or dendrite in the laser spot.
. Conclusion
We  established high-efﬁciency transduction and neuron-
peciﬁc expression of ChR2opt mediated by the rAAV6 serotype and
he hSyn promoter. Using this strategy, successful manipulation
f neuronal activity with single cell selectivity and good tempo-
al accuracy after blue light activation of ChR2opt was  achieved.
e demonstrated rAAV6 as a suitable vector for transferring a
ene into primary cortical neurons in vitro. To improve the efﬁ-
iency and speciﬁcity of expression, we invoked the hSyn promoter
o restrict gene expression to neurons. Notably, we could more
ffectively control neuronal activity with the hSyn-driven than the
MV-driven ChR2opt expression. Also, additional action potentials
ere generated when stimulating ChR2opt transduced neurons
ith longer pulses of blue laser light. In conclusion, rAAV6 with
Syn promoter driven constructs provides a useful tool for speciﬁ-
ally manipulating neuronal activity.
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